Editorial note: this article summarises published research on lipotropic injections, L-carnitine, MIC/B12 mixtures and Lemon Bottle. Baclabs does not sell these products or any peptide; we supply bacteriostatic water and reconstitution consumables. Nothing here is medical advice.
Lipotropic injections are the clinic-counter end of the fat-loss market: intramuscular or subcutaneous shots of L-carnitine, vitamin B12, or a “MIC” blend of methionine, inositol and choline sold under names such as Lipo-B and Lipo-C. Alongside them sits Lemon Bottle, a Korean “lipolysis solution” injected directly into fat pads by aesthetic practitioners. Familiar ingredients are not the same as evidence.
This article covers what each product contains, what the human data show, and where it stands under UK law. In short: L-carnitine has a modest oral evidence base, MIC blends have essentially none, B12 injections treat B12 deficiency and nothing else, and Lemon Bottle is not a licensed medicine anywhere and has failed laboratory testing of its contents.
What lipotropic injections are
A lipotrope is a substance that helps the liver process fat. The term comes from 1950s nutrition research in which choline, methionine, inositol and vitamin B12 reduced fat accumulation in the livers of rats fed deficient diets. That is a real effect in a deficiency model. The leap to injecting the same compounds into a well-nourished adult to lose body fat has never been demonstrated.
L-carnitine
L-carnitine transports long-chain fatty acids across the inner mitochondrial membrane so they can be oxidised. The body synthesises it, and most people obtain plenty from meat and dairy. The rationale for supplementation is that more carnitine means more fat burned; in practice muscle carnitine content is tightly regulated.
The human evidence is oral, not injectable. A 2020 systematic review and meta-analysis in Clinical Nutrition ESPEN pooled 37 randomised controlled trials with 2,292 participants and found that L-carnitine supplementation reduced body weight by a weighted mean of 1.21 kg (95 per cent CI −1.73 to −0.68), BMI by 0.24 kg/m² and fat mass by 2.08 kg. The dose-response was non-linear, with the largest weight effect at about 2,000 mg/day, and the effect was clearest in adults with overweight or obesity [1]. That is a small, real, oral effect. No equivalent trial exists for injected L-carnitine.
Lipo-B and Lipo-C: the MIC blend with B12
“Lipo-B” and “Lipo-C” are trade names used by compounding pharmacies and clinics for mixtures of methionine, inositol and choline (MIC), usually with cyanocobalamin or methylcobalamin (vitamin B12). Lipo-C formulations typically add vitamin C or additional B-complex vitamins, and some include L-carnitine. There is no fixed recipe; concentrations vary between suppliers.
Each ingredient has a plausible role in lipid metabolism. Methionine is a methyl donor; choline is needed to package triglyceride into very-low-density lipoprotein for export from the liver; inositol is a signalling molecule with a genuine evidence base in polycystic ovary syndrome (PCOS) and insulin resistance. None of that establishes that a weekly injection of the three causes fat loss in someone who is not deficient. There is no randomised controlled trial of MIC injections for weight loss; what clinics cite are the 1950s rat studies and reviews of the individual nutrients taken orally. Lipo-B and Lipo-C are compounded products with no efficacy evidence for their marketed purpose.
B12 injections and UK law
Vitamin B12 injections are effective treatment for B12 deficiency, particularly pernicious anaemia, where oral absorption fails. In someone with normal B12 status, an injection does not raise energy, speed metabolism or promote fat loss; the surplus is excreted.
The legal position in the UK is unambiguous. Injectable B12 (hydroxocobalamin and cyanocobalamin) is a prescription-only medicine (POM), a status that a 2020 petition debate in Parliament failed to change [6]. Answering a parliamentary question in April 2025, the Department of Health and Social Care confirmed that under the Human Medicines Regulations 2012 any medicine usually administered by injection must by law be classified as prescription-only, and that the Medicines and Healthcare products Regulatory Agency (MHRA) is therefore unable to reclassify B12 injections for over-the-counter sale [2]. The same logic covers L-carnitine and MIC injections: they can only be supplied against a prescription, and a salon or website offering them without one is acting unlawfully.
Lemon Bottle
Lemon Bottle is a different category. It is a South Korean injectable sold as a cosmetic “lipolysis solution” with declared ingredients of bromelain (a pineapple enzyme), riboflavin (vitamin B2) and lecithin. It has been heavily promoted on social media in the UK, and it is not a licensed medicine anywhere.
Three regulators have addressed it. The MHRA, asked about its status, said that in the absence of medicinal claims an injectable lipolysis product “isn’t considered a medicinal product unless it contains phosphatidylcholine or another active pharmaceutical ingredient”, which places Lemon Bottle outside medicines regulation and, in effect, outside any safety or efficacy assessment [3]. Swissmedic took the opposite view: in March 2024 it classified Lemon Bottle as an unauthorised, and therefore illegal, medicinal product on the basis of its injectable form, and reported that laboratory analysis of samples found one batch containing only caffeine and another containing none of the ingredients listed on the packaging [4]. In April 2025 the General Pharmaceutical Council warned UK pharmacies that unlicensed, unregulated cosmetic injectables including Lemon Bottle “have potentially caused serious harm”, citing reports of severe bruising, infection, abscess and necrosis, and told pharmacy owners to carry out due diligence on suppliers and check their indemnity cover [5].
To be blunt: Lemon Bottle is not a medicine, has not been assessed for safety or efficacy by any medicines regulator, and has unreliable contents on independent testing. There is no published clinical trial of it. Reported fat reduction is anecdote; the adverse events are documented.
Comparison
| Product | Typical contents | Best human evidence | UK status |
|---|---|---|---|
| L-carnitine | L-carnitine solution, strength varies | Oral meta-analysis: −1.21 kg weight, −2.08 kg fat [1] | Injectable form is prescription-only |
| Lipo-B | Methionine, inositol, choline, B12 | No controlled trial for weight loss | Compounded medicine, prescription-only |
| Lipo-C | MIC, B12, vitamin C and/or B-complex | No controlled trial for weight loss | Compounded medicine, prescription-only |
| B12 injection | Hydroxocobalamin or cyanocobalamin 1 mg/mL | Effective for B12 deficiency only | Prescription-only medicine [2] |
| Lemon Bottle | Declared: bromelain, riboflavin, lecithin | None; contents unreliable on testing [4] | Sold as a cosmetic; not a licensed medicine [3][5] |
Doses and how these products are supplied
Unlike the peptides in this cluster, lipotropic products are supplied as ready-made solutions in multi-dose vials or single-dose ampoules, not as lyophilised powder. There is nothing to reconstitute. The dose is whatever the prescriber specifies for the individual patient, and the only figure with a trial basis is the oral L-carnitine range of up to 2,000 mg/day from the meta-analysis [1]. No injectable dose of L-carnitine, MIC or B12 has been validated for weight loss.
Multi-dose vials and preserved diluents
The one point of overlap with reconstitution practice is the multi-dose vial. Compounded MIC and L-carnitine solutions are usually preserved with benzyl alcohol for the same reason bacteriostatic water is: a vial that is punctured repeatedly needs a bacteriostatic agent to remain suitable for use, typically for up to 28 days after first puncture. The distinction between preserved and unpreserved diluents is explained in bacteriostatic water vs sterile water, and the storage rules in bacteriostatic water storage and shelf life. For lyophilised compounds that do need a diluent, Baclabs supplies UK-stocked bacteriostatic water in 30 mL vials; the reconstitution guide has the maths.
Within the metabolic peptides guide, lipotropic injections sit at the low-evidence end: familiar nutrients and no demonstrated fat-loss effect beyond a kilogram or so from oral L-carnitine. AOD-9604 has better trial data and the same absence of efficacy. Lemon Bottle is the one product here with a documented harm signal and no regulatory oversight.
Frequently asked questions
Do lipotropic injections work for weight loss?
Not on current evidence. Oral L-carnitine produces a mean weight reduction of about 1.2 kg in randomised trials. MIC blends (Lipo-B, Lipo-C) have no controlled trial showing weight loss, and B12 only helps if you are deficient. Any larger results reported by clinics reflect the diet and exercise programme sold alongside the injections.
What is the difference between Lipo-B and Lipo-C?
Both are compounded methionine–inositol–choline (MIC) blends with vitamin B12. Lipo-C usually adds vitamin C or extra B-complex vitamins, and some versions include L-carnitine. There is no standard formula, so two clinics’ “Lipo-C” may differ. Neither has efficacy evidence for fat loss.
Are B12 injections prescription-only in the UK?
Yes. Under the Human Medicines Regulations 2012 every injectable medicine is prescription-only, and the government confirmed in 2025 that the MHRA cannot reclassify B12 injections for over-the-counter sale. Salons or websites offering them without a prescriber are supplying unlawfully.
Is Lemon Bottle a licensed medicine?
No. It is sold as a cosmetic and has not been assessed by the MHRA or any other medicines regulator. Swissmedic classified it as an illegal medicinal product in 2024 after testing found batches that did not contain the declared ingredients, and the General Pharmaceutical Council warned in 2025 that such products have potentially caused serious harm.
References
- Effects of L-carnitine supplementation on weight loss and body composition: a systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. Talenezhad et al., Clinical Nutrition ESPEN, 2020
- Written question 44657: Vitamin B12 injections and prescription-only classification. UK Parliament, Department of Health and Social Care, 2025
- Navigating hype products (MHRA position on Lemon Bottle). IMCAS, 2024
- Swissmedic issues warning about the illegal medicinal product “Lemon Bottle” lipolysis solution. Swissmedic, 2024
- GPhC issues warning on sales of “fat-dissolving” Lemon Bottle injections. Pharmacy Magazine, 2025
- Removing classification of prescription-only medicine from injectable vitamin B12 (petition debate). Hansard, UK Parliament, 2020
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Bacteriostatic water is supplied for reconstitution of substances intended for research and for use as directed by a healthcare professional. Peptides and medicines discussed here may be unlicensed in the UK or prescription-only; consult a qualified clinician before using any medicine. Baclabs does not sell peptides.